amphetamine and dextroamphetamine
Making the shortlist for patient engagement and communications
Grace Communications has been shortlisted this year in both the PMi Awards and the Creative Floor Awards for an engaging creative campaign, putting patients at the forefront.
Mobilizing Agitation Detection in Children with ADHD
Marius Rus, founder of StressLess–the startup behind Tully–discusses wearable technologies for children with ADHD, autism, and other mental health conditions. He also shares his tips and lessons learned from founding...
Mobilizing Agitation Detection in Children with ADHD
Marius Rus, founder of StressLess–the startup behind Tully–discusses wearable technologies for children with ADHD, autism, and other mental health conditions. He also shares his tips and lessons learned from founding...
Takeda to sell Japan consumer health unit for $2.3bn
Deal helps to reduce debt accrued from Shire takeover
Takeda’s subcutaneous Entyvio formulation faces FDA rejection
Was seeking approval in moderate-to-severe ulcerative colitis
Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
First wave of new molecular entities has potential to generate 14 approvals
Takeda divests over-the-counter and prescription drugs to Stada for $660m
Japanese pharma said it has plans to divest $10bn in non-core assests
Takeda offloads select portfolio to Acino ahead of Shire takeover
Hopes to reduce debt before acquistion completion
Shire bags US approval for constipation drug Motegrity
Approval is boost as Takeda takeover nears completion
Takeda secures investor backing for £46bn Shire takeover
The deal is expected to close early next year
Shire’s angioedema drug Takhzyro claims EU approval
Approval shortly follows a green light in the US